Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells (Q73141156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

C Hurd

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Nag

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

N Khattree

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P Alban

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Dinda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

V K Moudgil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

Molecular and Cellular Biochemistry

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

49-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10544951%20AND%20SRC:MED&resulttype=core&format=json

Stoichiometry and site-specific phosphorylation of human progesterone receptor in native target cells and in the baculovirus expression system

1 November 2019

cites work

1 reference

12 December 2020

Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells

1 reference

12 December 2020

Ligand and DNA-dependent phosphorylation of human progesterone receptor in vitro

1 reference

12 December 2020

A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform

1 reference

12 December 2020

In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA

1 reference

12 December 2020

Hormonal chemoprevention of cancer in women

1 reference

12 December 2020

Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors

1 reference

12 December 2020

Phosphotryptic peptide analysis of human progesterone receptor. New phosphorylated sites formed in nuclei after hormone treatment

1 reference

12 December 2020

Hormone receptors: their role in predicting prognosis and response to endocrine therapy

1 reference

12 December 2020

Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.

1 reference

12 December 2020

Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo.

1 reference

12 December 2020

Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processing

1 reference

12 December 2020

Effects of progestins, estrogens, and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D.

1 reference

12 December 2020

Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line

1 reference

12 December 2020

Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function

1 reference

12 December 2020

Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands

1 reference

12 December 2020

Effects of antiprogestins on the rate of proliferation of breast cancer cells

1 reference

12 December 2020

Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells

1 reference

12 December 2020

Mechanisms of antihormone action

1 reference

12 December 2020

Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells

1 reference

12 December 2020

Growth stimulation of T47D human breast cancer cells by the anti-progestin RU486.

1 reference

12 December 2020

Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line

1 reference

12 December 2020

Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299.

1 reference

12 December 2020